Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QA108 in intermediate AMD
NCT05562219Phase 2Completed
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 2 trial of QA108 in age-related macular degeneration (AMD). Started Jun 2022; status: completed.
02
Drugs
QA108
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT05562219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05562219.